MINORYX THERAPEUTICS
Minoryx, they are committed to finding innovative treatments for life threatening rare diseases. They focus on pediatric diseases and they are currently working on treatments for neurometabolic diseases of genetic origin.Minoryx develops a new generation of small molecule drugs known as pharmacological chaperones, which offer the most promising approach to the treatment of genetic diseases severely affecting the central nervous system. As a complementary approach, Minoryx is also involved in repositioning-based projects.
MINORYX THERAPEUTICS
Social Links:
Industry:
Biotechnology Genetics Medical Pharmaceutical
Founded:
2011-01-01
Address:
Barcelona, Catalonia, Spain
Country:
Spain
Website Url:
http://www.minoryx.com
Total Employee:
11+
Status:
Active
Contact:
34 93 702 19 75
Email Addresses:
[email protected]
Total Funding:
143.91 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Global Site Tag Mobile Non Scaleable Content
Similar Organizations
Bluebird Bio
Bluebird Bio offers products based on the transformative potential of gene therapy for patients with genetic and orphan diseases.
Moderna Therapeutics
Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.
PaxVax
PaxVax is a start-up developing candidate oral vaccines for key infectious diseases.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Ysios Capital
Ysios Capital investment in Series C - Minoryx Therapeutics
Centre for the Development of Industrial Technology (CDTI)
Centre for the Development of Industrial Technology (CDTI) investment in Series C - Minoryx Therapeutics
Caixa Capital Risc
Caixa Capital Risc investment in Series C - Minoryx Therapeutics
Fund+
Fund+ investment in Series C - Minoryx Therapeutics
Columbus Venture Partners
Columbus Venture Partners investment in Series C - Minoryx Therapeutics
European Investment Bank
European Investment Bank investment in Debt Financing - Minoryx Therapeutics
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Minoryx Therapeutics
Kurma Partners
Kurma Partners investment in Series B - Minoryx Therapeutics
Fund+
Fund+ investment in Series B - Minoryx Therapeutics
S.R.I.W.
S.R.I.W. investment in Series B - Minoryx Therapeutics
Official Site Inspections
http://www.minoryx.com
- Host name: 87.106.237.121
- IP address: 87.106.237.121
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
